Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Endocrine 1

Conditions

Thyroid Cancer, Papillary 15Neuroendocrine Tumors 14Carcinoma, Neuroendocrine 9Pituitary Neoplasms 8Thyroid Neoplasms 6Pheochromocytoma 6Thyroid Carcinoma, Anaplastic 4Paraganglioma 4Neoplasms 4Multiple Endocrine Neoplasia Type 1 3Recurrence 2Rectal Neuroendocrine Tumor 2Neoplasm Metastasis 2Melanoma 2Cushing Syndrome 2Adenocarcinoma, Follicular 2Acromegaly 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Thyroid cancer, medullary 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Serotonin Syndrome 1Sarcoma 1SDH-Related Familial Paraganglioma 1Rectal Neuroendocrine Tumors 1Rectal Neoplasms 1Prostatitis 1Prostatic Neoplasms 1Pituitary Diseases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neuroendocrine Prostate Cancer × Endocrine × Clear all
NCT07024277 2025-06-17

Study of ZG006 in Participants With Neuroendocrine Prostate Cancer

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 2 Not yet recruiting
60 enrolled
EndocrineGenitourinary

Neuroendocrine Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡